ANIK

SEC source: 0001193125-26-335269 · ownership.xml · nonDerivative · entry 2

Fischetti Gary P · CIK 0001929510 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,015

SEC source: 0001193125-26-335269 · ownership.xml · nonDerivative · entry 1

Fischetti Gary P · CIK 0001929510 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,015

SEC source: 0001193125-26-279545 · ownership.xml · nonDerivative · entry 1

Fischetti Gary P · CIK 0001929510 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,015

F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2027 annual meeting of the Company's stockholders or June 18, 2027.

SEC source: 0001193125-26-279542 · ownership.xml · nonDerivative · entry 1

HENNEMAN JOHN B III · CIK 0001187572 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,273

F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2027 annual meeting of the Company's stockholders or June 18, 2027.

SEC source: 0001193125-26-279541 · ownership.xml · nonDerivative · entry 1

Richard Stephen · CIK 0001823843 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,273

F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2027 annual meeting of the Company's stockholders or June 18, 2027.

SEC source: 0001193125-26-279539 · ownership.xml · nonDerivative · entry 1

Capper Joseph H · CIK 0001456817 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,805

F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2027 annual meeting of the Company's stockholders or June 18, 2027.

SEC source: 0001193125-26-279535 · ownership.xml · nonDerivative · entry 1

CONLEY SHERYL L · CIK 0001238659 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,970

F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2027 annual meeting of the Company's stockholders or June 18, 2027.

SEC source: 0001193125-26-259520 · ownership.xml · derivative · entry 3

Griffin Stephen D. · CIK 0001831125 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,840

Underlying: Common Stock · 12,840 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.

F4 · derivative.exercise_date: On June 3, 2024, the Reporting Person was granted 38,520 RSUs vesting in three equal annual installments beginning on June 3, 2025. This transaction reflects the second vesting installment of such RSU award.

F4 · derivative.expiration_date: On June 3, 2024, the Reporting Person was granted 38,520 RSUs vesting in three equal annual installments beginning on June 3, 2025. This transaction reflects the second vesting installment of such RSU award.

SEC source: 0001193125-26-259520 · ownership.xml · nonDerivative · entry 2

Griffin Stephen D. · CIK 0001831125 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,973

F3 · shares: Reflects an aggregate of 3,769 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on June 3, 2026.

SEC source: 0001193125-26-259520 · ownership.xml · nonDerivative · entry 1

Griffin Stephen D. · CIK 0001831125 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,742

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.

F2 · balance_after: Includes 739 shares acquired on May 14, 2026 under the Anika Therapeutics, Inc. Employee Stock Purchase Plan.

SEC source: 0001193125-26-202704 · ownership.xml · nonDerivative · entry 1

HENNEMAN JOHN B III · CIK 0001187572 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,871

F1 · price: The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $14.595 to $14.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001193125-26-197887 · ownership.xml · nonDerivative · entry 1

Griffin Stephen D. · CIK 0001831125 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,163

F1 · price: The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.235 to $12.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001193125-26-120005 · ownership.xml · derivative · entry 3

McLeod Ian · CIK 0001447910 · SVP, CAO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,663

Underlying: Common Stock · 17,663 shares

Expires 2036-03-19

F4 · derivative.exercise_date: Represents a Premium Priced Stock Appreciation Right ("PPSAR") granted under the 2017 Plan. The PPSAR exercise price per share is equal to 110% of the Fair Market Value (as defined in the 2017 Plan) of a share of common stock on the Grant Date. The PPSAR vests in three equal annual installments beginning March 19, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date. The PPSAR is payable in cash, shares of common stock, or a combination thereof, at the Issuer's discretion, in accordance with the 2017 Plan, as amended, and the applicable award agreement.

SEC source: 0001193125-26-120005 · ownership.xml · derivative · entry 2

McLeod Ian · CIK 0001447910 · SVP, CAO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,194

Underlying: Common Stock · 11,194 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the contingent right to receive, at the Issuer's discretion, one share of the Issuer's common stock, or the cash equivalent of the closing price of one share of the Issuer's common stock, on each vest date, in accordance with the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan, as amended (the "2017 Plan"), and the applicable award agreement.

F3 · derivative.exercise_date: Vests fully on March 19, 2029, subject to the Reporting Person's continuous service to the Issuer as of such date.

F3 · derivative.expiration_date: Vests fully on March 19, 2029, subject to the Reporting Person's continuous service to the Issuer as of such date.

SEC source: 0001193125-26-120005 · ownership.xml · derivative · entry 1

McLeod Ian · CIK 0001447910 · SVP, CAO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,097

Underlying: Common Stock · 13,097 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the contingent right to receive, at the Issuer's discretion, one share of the Issuer's common stock, or the cash equivalent of the closing price of one share of the Issuer's common stock, on each vest date, in accordance with the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan, as amended (the "2017 Plan"), and the applicable award agreement.

F2 · derivative.exercise_date: Vests in three equal annual installments, with the first installment vesting on March 19, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date.

F2 · derivative.expiration_date: Vests in three equal annual installments, with the first installment vesting on March 19, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date.

SEC source: 0001193125-26-111511 · ownership.xml · derivative · entry 7

Colleran David · CIK 0001646558 · EVP, General Counsel, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,448

Underlying: Common Stock · 6,449 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.

F6 · derivative.exercise_date: On March 15, 2024, the Reporting Person was granted 19,345 RSUs vesting in three equal annual installments beginning on March 15, 2025. This transaction reflects the second vesting installment of such RSU award.

F6 · derivative.expiration_date: On March 15, 2024, the Reporting Person was granted 19,345 RSUs vesting in three equal annual installments beginning on March 15, 2025. This transaction reflects the second vesting installment of such RSU award.

SEC source: 0001193125-26-111511 · ownership.xml · nonDerivative · entry 5

Colleran David · CIK 0001646558 · EVP, General Counsel, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,570

F4 · shares: Reflects an aggregate of 1,893 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 15, 2026.

SEC source: 0001193125-26-111511 · ownership.xml · nonDerivative · entry 4

Colleran David · CIK 0001646558 · EVP, General Counsel, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,463

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.

SEC source: 0001193125-26-111494 · ownership.xml · derivative · entry 8

Blanchard Cheryl R · CIK 0001326530 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,132

Underlying: Common Stock · 25,131 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.

F7 · derivative.exercise_date: On March 15, 2024, the Reporting Person was granted 75,395 RSUs vesting in three equal annual installments beginning on March 15, 2025. This transaction reflects the second vesting installment of such RSU award.

F7 · derivative.expiration_date: On March 15, 2024, the Reporting Person was granted 75,395 RSUs vesting in three equal annual installments beginning on March 15, 2025. This transaction reflects the second vesting installment of such RSU award.

SEC source: 0001193125-26-111494 · ownership.xml · nonDerivative · entry 5

Blanchard Cheryl R · CIK 0001326530 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 258,788

F4 · shares: Reflects an aggregate of 12,104 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 15, 2026.

SEC source: 0001193125-26-111494 · ownership.xml · nonDerivative · entry 4

Blanchard Cheryl R · CIK 0001326530 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 270,892

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.

SEC source: 0001193125-26-111492 · ownership.xml · derivative · entry 7

McLeod Ian · CIK 0001447910 · SVP, CAO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,659

Underlying: Common Stock · 2,658 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.

F6 · derivative.exercise_date: On March 15, 2024, the Reporting Person was granted 7,976 RSUs vesting in three equal annual installments beginning on March 15, 2025. This transaction reflects the second vesting installment of such RSU award.

F6 · derivative.expiration_date: On March 15, 2024, the Reporting Person was granted 7,976 RSUs vesting in three equal annual installments beginning on March 15, 2025. This transaction reflects the second vesting installment of such RSU award.

SEC source: 0001193125-26-111492 · ownership.xml · nonDerivative · entry 5

McLeod Ian · CIK 0001447910 · SVP, CAO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,107

F4 · shares: Reflects an aggregate of 781 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 15, 2026.

SEC source: 0001193125-26-111492 · ownership.xml · nonDerivative · entry 4

McLeod Ian · CIK 0001447910 · SVP, CAO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,888

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.

SEC source: 0001193125-26-111511 · ownership.xml · derivative · entry 6

Colleran David · CIK 0001646558 · EVP, General Counsel, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,777

Underlying: Common Stock · 9,388 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.

F5 · derivative.exercise_date: On March 14, 2025, the Reporting Person was granted 28,165 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award.

F5 · derivative.expiration_date: On March 14, 2025, the Reporting Person was granted 28,165 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award.

SEC source: 0001193125-26-111511 · ownership.xml · nonDerivative · entry 3

Colleran David · CIK 0001646558 · EVP, General Counsel, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,014

F3 · shares: Reflects an aggregate of 4,694 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs and PSUs that vested on March 14, 2026.

SEC source: 0001193125-26-111511 · ownership.xml · nonDerivative · entry 2

Colleran David · CIK 0001646558 · EVP, General Counsel, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,182

F2 · shares: On March 14, 2025, the Reporting Person was granted 14,082 performance-based phantom RSUs ("PSUs") with vesting contingent upon the achievement of pre-established performance and strategic targets. This transaction represents the first vesting installment of such PSU award.

SEC source: 0001193125-26-111511 · ownership.xml · nonDerivative · entry 1

Colleran David · CIK 0001646558 · EVP, General Counsel, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,488

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.

SEC source: 0001193125-26-111502 · ownership.xml · derivative · entry 4

Griffin Stephen D. · CIK 0001831125 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,649

Underlying: Common Stock · 12,824 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.

F4 · derivative.exercise_date: On March 14, 2025, the Reporting Person was granted 38,473 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award.

F4 · derivative.expiration_date: On March 14, 2025, the Reporting Person was granted 38,473 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award.

SEC source: 0001193125-26-111502 · ownership.xml · nonDerivative · entry 3

Griffin Stephen D. · CIK 0001831125 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,963

F3 · shares: Reflects an aggregate of 5,944 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs and PSUs that vested on March 14, 2026.

SEC source: 0001193125-26-111502 · ownership.xml · nonDerivative · entry 2

Griffin Stephen D. · CIK 0001831125 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,907

F2 · shares: On March 14, 2025, the Reporting Person was granted 19,236 performance-based phantom RSUs ("PSUs") with vesting contingent upon the achievement of pre-established performance and strategic targets. This transaction represents the first vesting installment of such PSU award.

SEC source: 0001193125-26-111502 · ownership.xml · nonDerivative · entry 1

Griffin Stephen D. · CIK 0001831125 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,495

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.

SEC source: 0001193125-26-111494 · ownership.xml · derivative · entry 7

Blanchard Cheryl R · CIK 0001326530 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,040

Underlying: Common Stock · 24,519 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.

F6 · derivative.exercise_date: On March 14, 2025, the Reporting Person was granted 73,559 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award.

F6 · derivative.expiration_date: On March 14, 2025, the Reporting Person was granted 73,559 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award.

SEC source: 0001193125-26-111494 · ownership.xml · nonDerivative · entry 3

Blanchard Cheryl R · CIK 0001326530 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 245,761

F3 · shares: Reflects an aggregate of 14,728 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs and PSUs that vested on March 14, 2026.

SEC source: 0001193125-26-111494 · ownership.xml · nonDerivative · entry 2

Blanchard Cheryl R · CIK 0001326530 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 260,489

F2 · shares: On March 14, 2025, the Reporting Person was granted 73,559 performance-based phantom RSUs ("PSUs") with vesting contingent upon the achievement of pre-established performance and strategic targets. This transaction represents the first vesting installment of such PSU award.

SEC source: 0001193125-26-111494 · ownership.xml · nonDerivative · entry 1

Blanchard Cheryl R · CIK 0001326530 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 235,969

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.

SEC source: 0001193125-26-111492 · ownership.xml · derivative · entry 6

McLeod Ian · CIK 0001447910 · SVP, CAO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,550

Underlying: Common Stock · 3,774 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.

F5 · derivative.exercise_date: On March 14, 2025, the Reporting Person was granted 11,324 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award.

F5 · derivative.expiration_date: On March 14, 2025, the Reporting Person was granted 11,324 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award.

SEC source: 0001193125-26-111492 · ownership.xml · nonDerivative · entry 3

McLeod Ian · CIK 0001447910 · SVP, CAO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,230

F3 · shares: Reflects an aggregate of 1,449 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs and PSUs that vested on March 14, 2026.

SEC source: 0001193125-26-111492 · ownership.xml · nonDerivative · entry 2

McLeod Ian · CIK 0001447910 · SVP, CAO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,679

F2 · shares: On March 14, 2025, the Reporting Person was granted 3,484 performance-based phantom RSUs ("PSUs") with vesting contingent upon the achievement of pre-established performance and strategic targets. This transaction represents the first vesting installment of such PSU award.

SEC source: 0001193125-26-111492 · ownership.xml · nonDerivative · entry 1

McLeod Ian · CIK 0001447910 · SVP, CAO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,518

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.

SEC source: 0001193125-26-102239 · ownership.xml · derivative · entry 4

Blanchard Cheryl R · CIK 0001326530 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,001 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.

F4 · derivative.exercise_date: On March 9, 2023, the Reporting Person was granted 60,004 RSUs vesting in three equal annual installments beginning on March 9, 2024. This transaction reflects the third and final vesting installment of such RSU award.

F4 · derivative.expiration_date: On March 9, 2023, the Reporting Person was granted 60,004 RSUs vesting in three equal annual installments beginning on March 9, 2024. This transaction reflects the third and final vesting installment of such RSU award.

SEC source: 0001193125-26-102239 · ownership.xml · nonDerivative · entry 2

Blanchard Cheryl R · CIK 0001326530 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 211,450

F2 · shares: Reflects an aggregate of 5,871 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2026.

SEC source: 0001193125-26-102239 · ownership.xml · nonDerivative · entry 1

Blanchard Cheryl R · CIK 0001326530 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 217,321

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.

SEC source: 0001193125-26-102240 · ownership.xml · derivative · entry 3

Colleran David · CIK 0001646558 · EVP, General Counsel, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,465 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.

F4 · derivative.exercise_date: On March 9, 2023, the Reporting Person was granted 16,395 RSUs vesting in three equal annual installments beginning on March 9, 2024. This transaction reflects the third and final vesting installment of such RSU award.

F4 · derivative.expiration_date: On March 9, 2023, the Reporting Person was granted 16,395 RSUs vesting in three equal annual installments beginning on March 9, 2024. This transaction reflects the third and final vesting installment of such RSU award.

SEC source: 0001193125-26-102240 · ownership.xml · nonDerivative · entry 2

Colleran David · CIK 0001646558 · EVP, General Counsel, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,100

F3 · shares: Reflects an aggregate of 1,919 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2026.

SEC source: 0001193125-26-102240 · ownership.xml · nonDerivative · entry 1

Colleran David · CIK 0001646558 · EVP, General Counsel, Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,019

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.

F2 · balance_after: Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 800 shares purchased on May 14, 2025 and 800 shares purchased on November 14, 2025.

SEC source: 0001193125-26-102238 · ownership.xml · derivative · entry 3

McLeod Ian · CIK 0001447910 · SVP, CAO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,197 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.

F4 · derivative.exercise_date: On March 9, 2023, the Reporting Person was granted 6,590 RSUs vesting in three equal annual installments beginning on March 9, 2024. This transaction reflects the third and final vesting installment of such RSU award.

F4 · derivative.expiration_date: On March 9, 2023, the Reporting Person was granted 6,590 RSUs vesting in three equal annual installments beginning on March 9, 2024. This transaction reflects the third and final vesting installment of such RSU award.

SEC source: 0001193125-26-102238 · ownership.xml · nonDerivative · entry 2

McLeod Ian · CIK 0001447910 · SVP, CAO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,744

F3 · shares: Reflects an aggregate of 639 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2026.

SEC source: 0001193125-26-102238 · ownership.xml · nonDerivative · entry 1

McLeod Ian · CIK 0001447910 · SVP, CAO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,383

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.

F2 · balance_after: Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 528 shares purchased on May 14, 2025 and 616 shares purchased on November 14, 2025.

SEC source: 0001193125-26-036129 · ownership.xml · derivative · entry 3

Griffin Stephen D. · CIK 0001831125 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,402

Underlying: Common Stock · 130,402 shares

Expires not disclosed

F4 · derivative.exercise_price: Each RSU represents the contingent right to receive, at the Issuer's discretion, one share of the Issuer's common stock, or the cash equivalent of the closing price of one share of the Issuer's common stock, on each vest date, in accordance with the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan, as amended, and the applicable award agreement.

F3 · derivative.exercise_date: Vests in three equal annual installments, with the first installment vesting on February 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date.

F3 · derivative.expiration_date: Vests in three equal annual installments, with the first installment vesting on February 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date.